Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis-Reference-Cited by-同舟云学术

Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis

Published:2018-02-12 Issue:6 Volume:22 Page:989-997
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

He Chaobin,Zhang Yu,Lin Xiaojun^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/article/10.1007/s11605-018-3703-3/fulltext.html

Reference49 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA: a cancer journal for clinicians. 2017;67(1):7–30. https://doi.org/10.3322/caac.21387 .

2. Raza A, Sood GK. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World journal of gastroenterology. 2014;20(15):4115–27. https://doi.org/10.3748/wjg.v20.i15.4115 .

3. Zhang J, Zhou ZG, Huang ZX, Yang KL, Chen JC, Chen JB et al. Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma. Chinese journal of cancer. 2016;35:25. https://doi.org/10.1186/s40880-016-0088-0 .

4. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134(7):1908–16. https://doi.org/10.1053/j.gastro.2008.02.091 .

5. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology (Baltimore, Md). 2011;53(3):1020–2. https://doi.org/10.1002/hep.24199 .

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives;Journal of Hematology & Oncology;2024-04-29

2. Prognosis of Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization(MC-hccAI 001): Development and Validation of the ALFP Score;Journal of Hepatocellular Carcinoma;2023-08

3. Recent advances in oncolytic virus therapy for hepatocellular carcinoma;Frontiers in Oncology;2023-04-26

4. Oncolytic virus-based hepatocellular carcinoma treatment: Current status, intravenous delivery strategies, and emerging combination therapeutic solutions;Asian Journal of Pharmaceutical Sciences;2023-01

5. Prognostic factors of survival in patients with non-small cell lung cancer: a competing risk model using the SEER database;Translational Cancer Research;2022-11